@jmikhaelmd@szusmani The best part of ASH (besides the new data) is catching up with friends! So glad you two were able to enjoy the calm before the storm! Cheers!
Congrats to my amazing friend, inspirational leader & myeloma savant @jmikhaelmd on election next @ASH_hematology Treasurer! The field of hematology will be enriched by his passion and vision! @Rfonsi1 @IMFmyeloma @cityofhope @TGen
I am excited to join @medscape and @medscapecme for this discussion on the latest data and impacts in oncology. #OncTwitter
Register to watch here: https://t.co/veNlpar3IW
We are pleased to share @US_FDA has accepted the New Drug Application (NDA) for patisiran, our investigational #RNAi therapeutic for the treatment of #hATTR#amyloidosis, and granted it Priority Review Status. https://t.co/AjzXt3JxEt